Stocks
ZIOPHARM Oncology, Inc.ZIOP
NASDAQHealthcareBiotechnology$0.87-0.88%
Focused on developing novel immunotherapies for cancer treatment, this biotech firm specializes in genetically modified T-cell therapies. Investors monitor its clinical-stage pipeline, particularly its collaborations with major cancer centers, as it seeks to advance treatments for solid tumors.
Market Cap: $208.1M52W Range: $0.76 – $5.95
Congressional Interest in ZIOPHARM Oncology, Inc. (ZIOP)
1 member of Congress has disclosed 1 trade in ZIOPHARM Oncology, Inc. (ZIOP), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ZIOP?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-18 | Mark R Warner | sell | $250K – $500K |